Certification of Wild Polio-Free Status
On 25 August 2020, the Africa Regional Certification Commission (ARCC) certified the entire WHO African Region — 47 countries — free of wild poliovirus, after four years without a single confirmed case. The certification followed an exhaustive review of surveillance, immunisation coverage, and laboratory capacity across the region, including field verification visits; Nigeria was one of four countries, alongside Cameroon, the Central African Republic, and South Sudan, whose documentation required this additional detailed field examination before sign-off S1S2. Nigeria mattered specifically because it was the last country in the entire WHO African Region to report a wild poliovirus case, making its clearance the final piece needed for regional certification S3. The 2020 certification made the African Region the fifth of six WHO regions declared wild polio-free, leaving Pakistan and Afghanistan as the only countries worldwide still reporting endemic wild poliovirus transmission S1
The Long Campaign Since 1996
The effort dates to 1996, when African heads of state meeting at the Organisation of African Unity summit in Yaoundé, Cameroon, committed to a continent-wide eradication push under the "Kick Polio Out of Africa" banner, at a time when wild poliovirus was paralysing an estimated 75,000 African children a year S4. Nigeria's campaign relied on repeated national immunisation days delivering oral polio vaccine door-to-door, coordinated by the National Primary Health Care Development Agency (NPHCDA) together with the World Health Organization, UNICEF, and Rotary International, whose "PolioPlus" programme contributed close to $890 million toward eradication efforts across Africa over the campaign's history S4
The 2003–2004 Vaccine Boycott
The campaign's most serious setback came in 2003, when several northern Nigerian states, led by Kano, suspended oral polio vaccination for roughly a year over rumours — spread by some local political and religious figures — that the vaccine was contaminated with HIV or an anti-fertility agent intended to sterilise young girls; these claims were not supported by any accepted evidence, a distinction the site records rather than adjudicates. Kano lifted its suspension in July 2004 after independent testing was arranged to reassure state authorities, and a large synchronised immunisation campaign followed in November 2004 across 23 African countries. The interruption had a measurable cost: nationally, confirmed wild poliovirus cases rose from 355 across 19 states in 2003 to 682 across 31 states in 2004, and the boycott is credited with re-seeding the virus into at least ten previously polio-free African countries — an episode that illustrates how public trust in immunisation can intersect with religious and political authority, a dynamic also visible in Nigeria's broader religious landscape at religion in nigeria S5
Rebuilding Trust After the Boycott
Following the 2003–2004 boycott, Nigeria's campaign shifted toward community-level trust-building rather than top-down vaccination drives alone. From 2012, health authorities and international partners deployed a Volunteer Community Mobilizer (VCM) network across high-risk northern states, including Kano, Kebbi, Bauchi, and Kaduna, recruiting local residents — including women — to conduct door-to-door engagement, address vaccine hesitancy, and identify unimmunised ("zero-dose") children. A UN-commissioned evaluation covering 2012–2020 found the network significantly increased oral polio vaccine coverage and reduced the number of zero-dose children, describing its impact on immunisation outcomes as high, while cautioning that sustaining these gains depended on continued support once VCM funding wound down S7
Borno State: The Last Wild Poliovirus Cases
After more than two years without a detected case, Nigeria reported three laboratory-confirmed wild poliovirus type 1 (WPV1) cases with onset between July and August 2016, all in Borno State — the epicentre of the Boko Haram insurgency, where conflict had left immunisation teams unable to reach large mobile and displaced populations for years. No wild poliovirus case has been confirmed anywhere in Nigeria, or the wider WHO African Region, since 2016, the case count that ultimately underpinned the 2020 regional certification S3S4
Beyond Wild Polio: Vaccine-Derived Poliovirus
Certification against wild poliovirus does not mean Nigeria is free of polio transmission altogether, and the distinction matters. Oral polio vaccine contains a weakened live virus that, in under-immunised communities, can circulate long enough to regain the ability to cause paralysis — a phenomenon called circulating vaccine-derived poliovirus (cVDPV), genetically and epidemiologically distinct from the wild virus that was eradicated. Nigeria recorded 98 confirmed cVDPV2 cases in 2024, concentrated in northern states including Kano, Borno, and Jigawa, with further cases confirmed into 2025; the Global Polio Eradication Initiative has sent high-level delegations to Nigeria specifically to address continuing cVDPV2 transmission, which health officials attribute to persistent gaps in routine immunisation coverage compounded by insecurity in affected areas S6
Outlook
Nigeria's dual status — certified free of wild poliovirus since 2020, yet still managing active cVDPV2 transmission — reflects a broader pattern in the country's public health system, where formal institutional capacity coexists with uneven service reach, as described at nigeria healthcare system. Outbreak surveillance for both wild and vaccine-derived polio now runs through the country's disease-control infrastructure, detailed at ncdc S6